Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-01-01
2008-01-01
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S500000, C564S503000, C564S509000, C514S665000, C514S667000, C514S671000, C514S674000
Reexamination Certificate
active
10915089
ABSTRACT:
The invention provides novel polyamine and amino thiol compounds and pharmaceutical compositions for administration in conjunction with cancer chemotherapy or radiation therapy. The compounds are administered locally to provide protection against the adverse side-effects of chemotherapy or radiation therapy, such as alopecia, mucositis and dermatitis. Pharmaceutical preparations comprising one or more chemoprotective polyamines or amino thiols formulated for topical or local delivery to epithelial or mucosal cells are disclosed. Methods of administering the pharmaceutical preparations are also disclosed.
REFERENCES:
patent: 3773833 (1973-11-01), Henrici et al.
patent: 5217964 (1993-06-01), Edwards et al.
patent: 5292497 (1994-03-01), Schein et al.
patent: 5434145 (1995-07-01), Edwards et al.
patent: 5541230 (1996-07-01), Basu et al.
patent: 5627215 (1997-05-01), Frei et al.
patent: 5889061 (1999-03-01), Frydman et al.
patent: 5962533 (1999-10-01), Bergeron, Jr.
patent: 6172261 (2001-01-01), Vermeulin et al.
patent: 6239119 (2001-05-01), Stogniew et al.
patent: 2003/0022867 (2003-01-01), Stogniew et al.
patent: 2003/0118539 (2003-06-01), Fahl et al.
patent: WO 94/19311 (1994-09-01), None
patent: WO 94/27961 (1994-12-01), None
patent: WO 98/17624 (1998-04-01), None
patent: WO 00/66587 (2000-11-01), None
patent: WO 00/78289 (2000-12-01), None
patent: WO 01/85142 1 (2001-11-01), None
patent: WO 02/38105 (2002-05-01), None
patent: WO 03/013245 (2003-02-01), None
patent: WO 03/066572 (2003-08-01), None
Database CAPLUS on STN, Acc. No. 1985:560304, Furukawa et al., EP 144825 (Jun. 19, 2006) (abstract).
Alvarez, E., et al., “Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis,”Clin. Cancer Research, 2003, 9, 3454-3461.
Aphramaian, M., et al., “Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine,”Biol. of the Cell, 1987, 61, 69-76.
Basu, H., et al., “The interaction of spermine and pentamines with DNA,”Biochem. J., 1987, 244, 243-246.
Basu, H., et al., “Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes,”Biochem. J., 1990, 269, 329-334.
Basu, H., et al., “Correlation between the effects of polyamine analogues on DNA conformation and cell growth,”Cancer Res., 1989, 49, 5591-5597.
Chen, G., et al., “Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3in mice,”Int. J. Cancer, 1998, 75, 303-309.
Creaven, P., et al., “Unusual central nervous system toxicity in a phase I study of N1N1diethylnorspermine in patients with advanced malignancy,”Invest. New Drugs, 1997, 15, 227-234.
Desai, M.P., et al., “The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent,”Pharm. Res., 1997, 14(11), 1568-1573.
Ellouk-Achard, S., et al., “ExVivo andExVitro models in acetaminophen hepatotoxicity studies. Relationship between glutathione depletion, exidative stress and disturbances in calcium homeostasis and energy metabolism,” Arch.Toxicol. Suppl.,1995, 17, 209-214.
Feuerstein, B., et al., “Molecular dynamics of spermine—DNA interations: sequence specificity and DNA bending for a simple ligand,”Nuc. Acids Res., 1989, 17(17), 6883-6892.
Gao, X., et al., “Radioprotective effect of epinephrine as a vasoconstrictor in mouse oral mucosa and scalp,”Okayama Igakkai Zasshi, 1996, 108, 139-144 (Translation).
Hillery, A.M., et al., “Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60nm polystyrene particles,”J. Drug Targeting, 1994, 2, 151-156.
Ho, D., et al., “Modification of glutathione levels in C3H/1OT1/2 cells and its relationship to benzo(α)pyrene anti-7,8-dihydrodiol 9,10-epoxide-induced cytotoxicity,”J. Biol. Chem., 1984, 259(18), 11231-11235.
Huber, M., et al., “2,2′-dithiobis(N-ethyl-spermine-5-carboxamide) is a high affinity, membrane-impermeant antagonist of the mammalian polyamine transport system,”J. Biol. Chem., 1996, 217(44), 27556-27563.
Hussein, A.M., et al., “Protection from chemotherapy-induced alopecia in a rat model,”Science, 1990, 249, 1564-1566.
Jayaraman, S.C., et al., “Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study,”J. Pharm. Sci., 1996, 85(10), 1082-1084.
Jeitner, T.M., et al., “Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine,”Cancer Lett., 1996, 103(1), 85-90.
Kramer, D.L., et al., “Polyamine analogue induction of the p. 53-p. 21WAFI/CIP1-Rb pathway and G1arrest in human melanoma cells,”Cancer Res., 1999, 59, 1278-1286.
Kramer, D.L., et al., “Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells,”Cancer Res., 1997, 57, 5521-5527.
Kramer, D.L., et al., “Polyamine depletion in human melanoma cells leads to G1arrest associated with induction of P. 21WAFI/CIPI/SDII, changes in the expression of p.21-regulated genes, and a senescence-like phenotype,”Cancer Res., 2001, 61, 7754-7762.
Levy, E., et al., “Transport of glutathione diethyl ester into human cells,”Proc. Natl. Acad. Sci. USA, 1993, 90(19), 9171-9175.
Lowy, R.O., et al., “Protection against local irradiation injury to the skin by locally and systemically applied drugs,”Radiation Biology, 1972, 105, 425-428.
March, J., Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 4thEd.,John Wiley&Sons, 1992, 771-780.
Masuda, K., et al., “Response of previously irradiated mouse skin to a second course of irradiation: early skin reaction and skin shrinkage,”Int. J. Radiation Oncol. Biol. Phys., 1986, 12, 1645-1651.
Purdie, J.W., “A comparative study of the radioprotective effects of cysteamine, WR-2721, and WR-1065 in cultured human cells,”Radiation Res., 1979, 77, 303-311.
Snyder, R.D., et al., “Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II,”Cancer Res., 2000, 60, 1186-1188.
Sonis, S.T., et al., “Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters,”Oral Oncology, 2000, 36, 373-381.
Spotheim-Maurizot, M., “radioprotection of DNA by polyamines,”Int. J. Radiat. Biol., 1995, 68(5), 571-577.
Streiff, R., et al., “Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies,”Invest. New Drugs, 2001, 19, 29-39.
Verhey, L.J., et al., “Determination of the radioprotective effects of topical applications of MEA, WR-2721, andN-acetylcysteine on murine skin,”Radiation Res., 1983, 93, 175-183.
U.S. Appl. No. 09/565,714, filed May 5, 2000, Fahl et al.
U.S. Appl. No. 10/214,917, filed Aug. 7, 2002, Fahl et al.
Piper, J.R., et al., “S-2,ω-diaminoalkyl dihydrogen phosphorothioates as antiradiation agents,”Am. Chem. Soc., 1979, 631-639.
Copp Richard C.
Fahl William E.
Peebles Daniel D.
Davis Brian
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Amino thiol compounds and compositions for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino thiol compounds and compositions for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino thiol compounds and compositions for use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3919851